{
    "id": 23645,
    "cites": 38,
    "cited_by": 6,
    "reference": [
        "Alpert, A., D. Powell, and R.L. Pacula. \u00c3\u00a2\u00e2\u0082\u00ac\u00c5\u0093Supply-Side Drug Policy in the Presence of Substitutes: Evidence from the Introduction of Abuse-Deterrent Opioids,\u00c3\u00a2\u00e2\u0082\u00ac\u00c2\u009d RAND Working Paper No. WR1181. 2016.",
        "Antman, K.H., H.A. Berman, T.R. Flotte, J. Flier, D.M. Dimitri, M. Bharel. \u00c3\u00a2\u00e2\u0082\u00ac\u00c5\u0093Developing Core Competencies for the Prevention and Management of Prescription Drug Misuse: A Medical Education Collaboration in Massachusetts,\u00c3\u00a2\u00e2\u0082\u00ac\u00c2\u009d Academic Medicine. 2016; 91(10): 1348-1351.",
        "Bao, Y., Y. Pan, A. Taylor, S. Radakrishnan, F. Luo, H.A. Pincus, and B.R. Schackman. \u00c3\u00a2\u00e2\u0082\u00ac\u00c5\u0093Prescription Drug Monitoring Programs are Associated with Sustained Reductions In Opioid Prescribing by Physicians,\u00c3\u00a2\u00e2\u0082\u00ac\u00c2\u009d Health Affairs. 2016; 35(6): 1045-1051.",
        "Barnett, M., A. Olenski, and A. Jena. \u00c3\u00a2\u00e2\u0082\u00ac\u00c5\u0093Opioid-Prescribing Patterns of Emergency Physicians and Risk of Long- Term Use,\u00c3\u00a2\u00e2\u0082\u00ac\u00c2\u009d The New England Journal of Medicine. 2017; 376: 663-673.",
        "Brewer, D., E. Eric, and R. Ehrenberg. \u00c3\u00a2\u00e2\u0082\u00ac\u00c5\u0093Does It Pay to Attend an Elite Private College? CrossCohort Evidence on the Effects of College Type on Earnings,\u00c3\u00a2\u00e2\u0082\u00ac\u00c2\u009d Journal of Human Resources. 1999; 34(1): 104\u00c3\u00a2\u00e2\u0082\u00ac\u00e2\u0080\u009c123.",
        "Buchmueller, T.C. and C. Carey. \u00c3\u00a2\u00e2\u0082\u00ac\u00c5\u0093The Effect of Prescription Drug Monitoring Programs on Opioid Utilization in Medicare,\u00c3\u00a2\u00e2\u0082\u00ac\u00c2\u009d NBER Working Paper No. 23148. 2017.",
        "Case, A. and A. Deaton. \u00c3\u00a2\u00e2\u0082\u00ac\u00c5\u0093Rising Morbidity and Mortality in Midlife Among White NonHispanic Americans in the 21st Century,\u00c3\u00a2\u00e2\u0082\u00ac\u00c2\u009d Proceedings of the National Academy of Sciences. 2015; 112(49): 15078-15083.",
        "Chen, L.H., H. Hedegaard, and M. Warner. \u00c3\u00a2\u00e2\u0082\u00ac\u00c5\u0093Drug-poisoning Deaths Involving Opioid Analgesics: United States, 1999\u00c3\u00a2\u00e2\u0082\u00ac\u00e2\u0080\u009c2011,\u00c3\u00a2\u00e2\u0082\u00ac\u00c2\u009d NCHS Data Brief No. 166. 2014.",
        "Coleman, J., E. Katz, and H. Menzel. \u00c3\u00a2\u00e2\u0082\u00ac\u00c5\u0093The Diffusion of an Innovation Among Physicians,\u00c3\u00a2\u00e2\u0082\u00ac\u00c2\u009d Sociometry. 1957; 20(4): 253-270.",
        "Dale, S.B. and A. Krueger. \u00c3\u00a2\u00e2\u0082\u00ac\u00c5\u0093Estimating the Payoff to Attending a More Selective College: An Application of Selection on Observables and Unobservables,\u00c3\u00a2\u00e2\u0082\u00ac\u00c2\u009d Quarterly Journal of Economics. 2002; 117(4): 1491-1527.",
        "Dart, R., H. Surratt, T. Cicero, M. Parrino, G. Severtson, B. Bucher-Bartelson, and J. Green. \u00c3\u00a2\u00e2\u0082\u00ac\u00c5\u0093Trends in Opioid Analgesic Abuse and Mortality in the United States,\u00c3\u00a2\u00e2\u0082\u00ac\u00c2\u009d The New England Journal of Medicine. 2015; 372: 241-248.",
        "Dave, D.M., A.M. Grecu, and H. Saffer. \u00c3\u00a2\u00e2\u0082\u00ac\u00c5\u0093Mandatory Access Prescription Drug Monitoring Programs and Prescription Drug Abuse,\u00c3\u00a2\u00e2\u0082\u00ac\u00c2\u009d NBER Working Paper No. 23537. 2017. 26 Dowell, D., T.M. Haegerich, R. Chou. \u00c3\u00a2\u00e2\u0082\u00ac\u00c5\u0093CDC Guideline for Prescribing Opioids for Chronic Pain\u00c3\u00a2\u00e2\u0082\u00ac\u00e2\u0080\u009dUnited States, 2016,\u00c3\u00a2\u00e2\u0082\u00ac\u00c2\u009d MMWR Recommendations and Reports. 2016; 65(1): 1-49.",
        "Dowell, D., K. Zhang, R.K. Noonan, and J.M. Hockenberry. \u00c3\u00a2\u00e2\u0082\u00ac\u00c5\u0093Mandatory Provider Review And Pain Clinic Laws Reduce The Amounts Of Opioids Prescribed And Overdose Death Rates,\u00c3\u00a2\u00e2\u0082\u00ac\u00c2\u009d Health Affairs. 2016; 35(10): 1876\u00c3\u00a2\u00e2\u0082\u00ac\u00e2\u0080\u009c1883.",
        "Doyle, J.J., S.M. Ewer, and T.H. Wagner. \u00c3\u00a2\u00e2\u0082\u00ac\u00c5\u0093Returns to Physician Human Capital: Evidence from Patients Randomized to Physician Teams,\u00c3\u00a2\u00e2\u0082\u00ac\u00c2\u009d Journal of Health Economics. 2010; 29(6): 866-882.",
        "Epstein, A.J. and S. Nicholson. \u00c3\u00a2\u00e2\u0082\u00ac\u00c5\u0093The Formation and Evolution of Physician Treatment Style: An Application to Cesarean Sections,\u00c3\u00a2\u00e2\u0082\u00ac\u00c2\u009d Journal of Health Economics. 2009; 28(6): 1126-1240.",
        "Epstein, A.J., S. Nicholson, and D.A. Asch. \u00c3\u00a2\u00e2\u0082\u00ac\u00c5\u0093The Production of and Market for New Physicians\u00c3\u00a2\u00e2\u0082\u00ac\u00e2\u0084\u00a2 Skill,\u00c3\u00a2\u00e2\u0082\u00ac\u00c2\u009d American Journal of Health Economics, 2016; 2(1): 41-65.",
        "Evans, W.N., E. Lieber, and P. Power. \u00c3\u00a2\u00e2\u0082\u00ac\u00c5\u0093How the Reformulation of OxyContin Ignited the Heroin Epidemic,\u00c3\u00a2\u00e2\u0082\u00ac\u00c2\u009d Working Paper. 2017.",
        "Haegerich, T., L. Paulozzi, B. Manns, and C. Jones. \u00c3\u00a2\u00e2\u0082\u00ac\u00c5\u0093What We Know, and Don&apos;t Know, About the Impact of State Policy and Systems-Level Interventions on Prescription Drug Overdose,\u00c3\u00a2\u00e2\u0082\u00ac\u00c2\u009d Drug and Alcohol Dependence. 2014; 145: 34-47.",
        "Hartz, A.J., E.M. Kuhn, and J. Pulido. \u00c3\u00a2\u00e2\u0082\u00ac\u00c5\u0093Prestige of training programs and experience of bypass surgeons as factors in adjusted patient mortality rates,\u00c3\u00a2\u00e2\u0082\u00ac\u00c2\u009d Medical Care. 1999; 37(1): 93\u00c3\u00a2\u00e2\u0082\u00ac\u00e2\u0080\u009c103. Health and Human Services, Substance Abuse and Mental Health Services Administration.",
        "\u00c3\u00a2\u00e2\u0082\u00ac\u00c5\u0093Results from the 2013 National Survey on Drug Use and Health: Summary of National Findings,\u00c3\u00a2\u00e2\u0082\u00ac\u00c2\u009d NSDUH Series H-48, HHS Publication No. (SMA) 14-4863. 2014.",
        "Hoekstra, M. \u00c3\u00a2\u00e2\u0082\u00ac\u00c5\u0093The Effect of Attending the Flagship State University on Earnings: A Discontinuity-Based Approach,\u00c3\u00a2\u00e2\u0082\u00ac\u00c2\u009d The Review of Economics and Statistics. 2009; 91(4): 717724.",
        "Hoxby, C.M. \u00c3\u00a2\u00e2\u0082\u00ac\u00c5\u0093The Changing Selectivity of American Colleges,\u00c3\u00a2\u00e2\u0082\u00ac\u00c2\u009d Journal of Economic Perspectives. 2009; 23(4): 95-118.",
        "Hoxby, C.M. \u00c3\u00a2\u00e2\u0082\u00ac\u00c5\u0093The Dramatic Economics of the US Market for Higher Education,\u00c3\u00a2\u00e2\u0082\u00ac\u00c2\u009d NBER Reporter. 2016; 3: 1-6.",
        "Kennedy-Hendricks, A., M. Richey, E.E. McGinty, E.A. Stuart, C.L. Barry, and D.W. Webster. \u00c3\u00a2\u00e2\u0082\u00ac\u00c5\u0093Opioid Overdose Deaths and Florida&apos;s Crackdown on Pill Mills,\u00c3\u00a2\u00e2\u0082\u00ac\u00c2\u009d American Journal of Public Health. 2016; 106(2): 291-297.",
        "Levy, B., L. Paulozzi, K. Mack, and C. Jones. \u00c3\u00a2\u00e2\u0082\u00ac\u00c5\u0093Trends in Opioid Analgesic-Prescribing Rates by Specialty, US, 2007-2012,\u00c3\u00a2\u00e2\u0082\u00ac\u00c2\u009d American Journal of Preventive Medicine. 2015; 49(3): 409-413. 27 Lucas, F.L., B.E. Sirovich, P.M. Gallagher, A.E. Siewers, and D.E. Wennberg. \u00c3\u00a2\u00e2\u0082\u00ac\u00c5\u0093Variation in Cardiologists\u00c3\u00a2\u00e2\u0082\u00ac\u00e2\u0084\u00a2 Propensity to Test and Treat: Is it Associated with Regional Variation in Utilization?,\u00c3\u00a2\u00e2\u0082\u00ac\u00c2\u009d Circulation: Cardiovascular Quality and Outcomes. 2010; 3(3): 253-260.",
        "Meara, E., J. Horwitz, W. Powell, L. McClelland, W. Zhou, J. O&apos;Malley, and N. Morden. \u00c3\u00a2\u00e2\u0082\u00ac\u00c5\u0093State Legal Restrictions and Prescription Opioid Use among Disabled Adults,\u00c3\u00a2\u00e2\u0082\u00ac\u00c2\u009d The New England Journal of Medicine. 2016; 375: 44-53.",
        "Meinhofer, A. \u00c3\u00a2\u00e2\u0082\u00ac\u00c5\u0093The War on Drugs: Estimating the Effect of Prescription Drug Supply-Side Interventions,\u00c3\u00a2\u00e2\u0082\u00ac\u00c2\u009d Working Paper. 2016.",
        "Mueller, S.R., A.Y. Walley, S.L. Calcaterra, J.M. Glanz, and I.A. Binswanger. \u00c3\u00a2\u00e2\u0082\u00ac\u00c5\u0093A Review of Opioid Overdose Prevention and Naloxone Prescribing: Implications for Translating Community Programming into Clinical Practice,\u00c3\u00a2\u00e2\u0082\u00ac\u00c2\u009d Substance Abuse. 2015; 36(2): 240\u00c3\u00a2\u00e2\u0082\u00ac\u00e2\u0080\u009c253.",
        "Patrick, S.W., C.E. Fry, T.F. Jones, and M.B. Buntin. \u00c3\u00a2\u00e2\u0082\u00ac\u00c5\u0093Implementation of Prescription Drug Monitoring Programs Associated With Reductions In Opioid-Related Death Rates,\u00c3\u00a2\u00e2\u0082\u00ac\u00c2\u009d Health Affairs. 2016; 35(7):1324\u00c3\u00a2\u00e2\u0082\u00ac\u00e2\u0080\u009c1332.",
        "Paulozzi, L.J., and E.M. Kilbourne, and H.A. Desai. \u00c3\u00a2\u00e2\u0082\u00ac\u00c5\u0093Prescription Drug Monitoring Programs and Death Rates from Drug Overdose,\u00c3\u00a2\u00e2\u0082\u00ac\u00c2\u009d Pain Medicine. 2011; 12(5): 747\u00c3\u00a2\u00e2\u0082\u00ac\u00e2\u0080\u009c54.",
        "Reifler, L.M., D. Droz, J.E. Bailey, S.H. Schnoll, R. Fant, R.C. Dart, and B. Bucher-Bartelson. \u00c3\u00a2\u00e2\u0082\u00ac\u00c5\u0093Do Prescription Monitoring Programs Impact State Trends in Opioid Abuse/Misuse?,\u00c3\u00a2\u00e2\u0082\u00ac\u00c2\u009d Pain Medicine. 2012; 13.",
        "Ringwalt, C., H. Gugelmann, M. Garrettson, N. Dasgupta, A. Chung, S. Proescholdbell, and A. Skinner. \u00c3\u00a2\u00e2\u0082\u00ac\u00c5\u0093Differential Prescribing of Opioid Analgesics According to Physician Specialty for Medicaid Patients with Chronic Noncancer Pain Diagnoses,\u00c3\u00a2\u00e2\u0082\u00ac\u00c2\u009d Pain Research and Management. 2014; 19(4): 179-185.",
        "Rudd, R., N. Aleshire, J. Zibbell, and M. Gladden. \u00c3\u00a2\u00e2\u0082\u00ac\u00c5\u0093Increases in Drug and Opioid Overdose Deaths\u00c3\u00a2\u00e2\u0082\u00ac\u00e2\u0080\u009dUnited States, 2000-2014,\u00c3\u00a2\u00e2\u0082\u00ac\u00c2\u009d Morbidity and Mortality Weekly Report (MMWR). 2016; 64(50): 1378-1382.",
        "Soumerai, S., T. McLaughlin, J. Gurwitz, E. Guadagnoli, P. Hauptman, C. Borbas, N. Morris, B. McLaughlin, X. Gao, D. Willison, R. Asinger, F. Gobel. \u00c3\u00a2\u00e2\u0082\u00ac\u00c5\u0093Effect of Local Medical Opinion Leaders on Quality of Care for Acute Myocardial Infarction: A Randomized Controlled Trial,\u00c3\u00a2\u00e2\u0082\u00ac\u00c2\u009d JAMA. 1998; 279: 1358-1363.",
        "Volkow, N., T. McLellan, J. Cotto, M. Karithanom, and S. Weiss. \u00c3\u00a2\u00e2\u0082\u00ac\u00c5\u0093Characteristics of Opioid Prescriptions in 2009,\u00c3\u00a2\u00e2\u0082\u00ac\u00c2\u009d JAMA. 2011; 305(13): 1299-1301.",
        "Cohort: 1996\u00c3\u00a2\u00cb\u0086\u00e2\u0080\u00992005 Annual opioid prescriptions per physician relative to Harvard (including zeroes) B. General practitioners \u00c3\u00a2\u00cb\u0086\u00e2\u0080\u0099100 0 100 200 300 H a r v a r d R a n k 2 \u00c3\u00a2\u00cb\u0086\u00e2\u0080\u0099 5 6 \u00c3\u00a2\u00cb\u0086\u00e2\u0080\u0099 1 0 1 1 \u00c3\u00a2\u00cb\u0086\u00e2\u0080\u0099 1 5 1 6 \u00c3\u00a2\u00cb\u0086\u00e2\u0080\u0099 2 0 2 1 \u00c3\u00a2\u00cb\u0086\u00e2\u0080\u0099 2 5 2 6 \u00c3\u00a2\u00cb\u0086\u00e2\u0080\u0099 3 0 3 1 \u00c3\u00a2\u00cb\u0086\u00e2\u0080\u0099 3 5 3 6 \u00c3\u00a2\u00cb\u0086\u00e2\u0080\u0099 4 0 4 1 \u00c3\u00a2\u00cb\u0086\u00e2\u0080\u0099 4 5 4 6 \u00c3\u00a2\u00cb\u0086\u00e2\u0080\u0099 5 0 5 1 \u00c3\u00a2\u00cb\u0086\u00e2\u0080\u0099 5 5 5 6 \u00c3\u00a2\u00cb\u0086\u00e2\u0080\u0099 6 0 6 1 \u00c3\u00a2\u00cb\u0086\u00e2\u0080\u0099 6 5 6 6 \u00c3\u00a2\u00cb\u0086\u00e2\u0080\u0099 7 0 7 1 \u00c3\u00a2\u00cb\u0086\u00e2\u0080\u0099 7 5 7 6 \u00c3\u00a2\u00cb\u0086\u00e2\u0080\u0099 8 0 8 1 \u00c3\u00a2\u00cb\u0086\u00e2\u0080\u0099 8 5 8 6 \u00c3\u00a2\u00cb\u0086\u00e2\u0080\u0099 9 2 U n r a n k e d ( M D ) U n r a n k e d ( D O ) F o r e i g n",
        "Cohort: 1996\u00c3\u00a2\u00cb\u0086\u00e2\u0080\u00992005 Annual opioid prescriptions per physician relative to Harvard (including zeroes) Notes: The above figures depict the coefficient estimates on indicators for medical school rank bins from regressions of opioid prescriptions at the physician-year level on medical school rank bin indicators with year, specialty, and county fixed effects (Equation (1)). Subfigure A includes all physicians; Subfigure B only includes GPs (physicians in general practice, family practice, and internal medicine). Physician-years with zero opioid prescriptions are included. The bars denote 95% confidence intervals; standard errors are clustered by physician.",
        "Table 2: Summary Statistics: County-Level Prescriptions and Mortality By year 2006 2007 2008 2009 2010 2011 2012 2013 2014 All N counties 3,140 3,140 3,140 3,140 3,140 3,140 3,140 3,140 3,140 3,140 N county-years . . . . . . . . . 28,260 Unweighted averages Opioid prescriptions/ capita 0.53 0.55 0.56 0.65 0.65 0.65 0.67 0.66 0.64 0.62 Total deaths/100,000 1008.1 1004.8 1024.6 1002.3 1000.0 1015.6 1024.8 1040.0 1050.9 1019.0 Deaths involving drugs/100,000 12.9 13.7 14.0 14.4 14.7 16.0 15.8 16.7 17.4 15.1 Population-weighted averages Opioid prescriptions/ capita 0.64 0.67 0.69 0.77 0.79 0.79 0.79 0.76 0.73 0.74 Total deaths/100,000 813.3 804.8 813.1 794.6 797.9 806.9 809.6 820.7 823.6 809.5 Deaths involving drugs/100,000 14.9 15.2 15.1 15.1 15.5 16.7 16.6 17.5 18.6 16.2 Notes: \u00c3\u00a2\u00e2\u0082\u00ac\u00c5\u0093Deaths involving drugs\u00c3\u00a2\u00e2\u0082\u00ac\u00c2\u009d include poisonings from drugs resulting in death as well as deaths in which drug dependence was indicated on the death certificate."
    ]
}